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C57Bl/6 Cas9 BMDM (bone-marrow derived macrophages from mice)	cells	were	immortalized	by	Pontus	Orning,	a	member	of	the	lab,	using	a	J2	retrovirus 
expressing v-raf and v-myc oncogenes. These are considered the immortalized wildtype 
macrophages. Additionally, Pontus used lentivirally delivered specific gRNA to generate 
the GSDMD knock-out cells (CRISPR-Cas9 technology). The cells were then verified for 
the gene knock-out by use of GSDMD specific antibody (Genentech).	Aliquots	of	these	cells	were	collected	from	-80°F	storage.	They	were	placed	on	dry	ice,	and	when	in	the	hood	they	were	partially	thawed	then	transferred	to	a	50mL	conical	tube	containing	10mL	of	DPBS.	The	cells	were	then	placed	into	the	centrifuge	and	spun	for	5min	at	4,000rpm	in	order	to	remove	the	DMSO	before	it	caused	harm	to	the	cells.	The	supernatant	was	decanted	and	the	pellet	was	resuspended	by	gentle	pipetting	in	10mL	of	serum-free	cell	culture	media	(DMEM).	The	cell	solution	was	removed	and	transferred	to	a	75cm	cell	culture	flask.	The	cells	were	then	incubated	at	37°C	with	daily	media	changes	until	they	reached	confluency.	At	this	point	the	cells	were	split.	This	was	done	by	aspirating	the	cell	media	over	the	entirety	of	the	flask	until	no	visible	colonies	of	cells	remained	adherent	to	the	bottom.	The	media	was	collected	into	a	50mL	conical	tube	and	centrifuged.	The	pellet	was	resuspended	in	cell	media	and	only	a	fraction	was	replaced	into	the	flask.	Cell	culture	media	was	then	added	to	the	flask	to	ensure	a	thorough	covering	of	the	bottom	of	the	flask	when	it	is	laid	on	its	side.	Cell	concentration	was	determined	by	manually	counting	the	number	of	viable	cells	using	40uL	of	Tryptan	Blue	dye	and	40uL	of	the	cell	suspension.	10uL	of	this	mixture	was	pipetted	onto	a	glass	slide	and	the	viable	cells	
were	counted	using	a	microscope.	This	number	was	then	multiplied	by	2	to	account	for	the	1:2	dilution	of	the	sample	with	Tryptan	Blue	and	then	again	multiplied	by	10,000	to	account	for	the	size	of	the	microscope	slide	and	the	total	volume	of	the	solution.	The	resulting	number	is	the	amount	of	cells	per	milliliter.	
2.2	Bacterial	Cell	Culture	
Salmonella	enterica	serovar Typhimurium, strain SL1344	and	Yersinia	pestis	










Yop J 1.892 
SL1334 1.839 
HilA 0.841 







V(mL) to add to 5mL of 
DMEM 
uL to add to 5mL of 
DMEM 
Kim5 719840000 10000000 0.0694599 69.46 
Yop J 832480000 10000000 0.0600615 60.06 
SL1334 1397640000 2000000 0.0357746 35.77 
HilA 639160000 2000000 0.0782277 78.23 
FlhD 2558160000 2000000 0.0195453 19.55 	 	The	cell	plate	was	aspirated	of	cell	media	and	the	bacteria-containing	cell	media	was	added	to	the	appropriate	wells.	Uninfected	DMEM	was	added	to	control	and	lysis	wells.	The	cells	were	covered	and	incubated	at	37°C	for	two	hours.	At	this	point,	10mg/mL	of	gentamycin	was	added	to	each	of	the	bacteria	containing	wells	to	limit	the	growth	of	the	bacterial	cells.	The	plate	was	then	incubated	for	and	additional	4	hours	to	ensure	maximum	infection	rates.	30min	before	the	harvest,	lysis	buffer	was	added	to	the	lysis	wells	to	serve	as	a	control	for	the	LDH	assay.			 This	experiment	resulted	in	an	LDH	plate	that	had	no	signal.	The	cause	of	the	blank	plate	was	not	discovered,	but	the	experiment	was	repeated.	All	new	cells	were	cultured	and	new	cell	media	was	used	to	eliminate	possible	sources	of	contamination.	After	repeating	the	infection,	another	LDH	assay	was	performed	following	the	procedure	in	chapter	2.4,	and	the	results	were	collected	into	Table	4	below.	
Table	4:	LDH	Assay	Absorbance	Data	
 
Wild Type GSDMD 
Blank 0.1538 0.1587 0.1449 0.1722 0.1671 0.1834 
Lysis 0.5249 0.5565 0.6534 0.6779 0.7106 0.764 
Kim5 0.2336 0.2885 0.2516 0.2883 0.2414 0.2894 
ΔYop J 0.2271 0.2278 0.2032 0.1725 0.1616 0.1719 
SL1334 0.4572 0.573 0.5125 0.5643 0.4231 0.6232 
SLΔFlhD 0.2182 0.2614 0.2392 0.2158 0.2125 0.1957 
































Kim5 0.887228 0.718364 0.697256 0.570608 0.528392 0.275096 
Yop J 1.858196 1.647116 1.224956 1.0772 0.718364 0.97166 
SL1334 5.79132 7.19852 2.8362 5.15808 2.62512 2.69548 
FlhD 5.50988 3.82124 3.11764 3.32872 1.99188 2.4844 
HilA 4.17304 3.188 2.41404 2.20296 1.71044 1.49936 	These	concentrations	in	nanograms	per	milliliter	were	graphed	to	visually	see	the	concentrations	of	IL-1	beta	across	all	of	the	different	samples.	This	can	be	seen	in	Figure	5	below.		
	
Figure	5:	Mouse	IL-1	beta	Concentrations			 Due	to	the	results	of	the	ELISA	correlating	with	the	LDH	results,	it	was	determined	that	the	Kim5	bacteria	samples	were	either	contaminated	or	some	external	factor	limited	the	virulence	of	the	bacteria.	The	other	bacterial	mutations	performed	as	expected.	The	mutations	all	caused	a	drop	in	the	total	cell	death	of	the	infected	macrophages.	This	confirms	that	these	specific	mutations	are	integral	to	cell	death	regulation	in	the	bacterium.	This	experiment	was	repeated	again	to	determine	better	results,	but	the	experiment	collected	incredibly	poor	data.	There	was	some	troubleshooting	conducted	again,	but	the	problems	were	not	resolved.	A	future	MQP	may	wish	to	investigate	why	these	infections	did	not	produce	the	expected	results.	 	
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Appendix	
Appendix	A:	Chromosome	Locations	of	Gasdermin	Family	Members	(Tamura	et	
al.,	2007)	
	
				 	
Appendix	B:	GSDMD	Molecular	Structure	and	Domain	Interaction	Sites	The	complete	molecular	structures	of	GSDMD	are	modeled	below.	The	sites	where	GSDMD-C	and	GSDMD-N	interact	are	shown	in	the	I	and	II	labeled	boxes	(Liu	et	al.,	2018).	
	
	
Appendix	C:	Yersinia	Pestis	Infection	via	Flea	Bite	Diagram	of	Yersinia	pestis	infection	of	host	organism	cell	types	(Li	&	Yang,	2008b).	
	
